RA
Rosalind Advisors Portfolio holdings
AUM
$207M
1-Year Return
62.29%
This Quarter Return
+8.64%
1 Year Return
+62.29%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$207M
AUM Growth
+$1.42M
(+0.69%)
Cap. Flow
-$1.6M
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
63.59%
Holding
43
New
4
Increased
7
Reduced
9
Closed
6
Top Buys
| 1 |
Cytokinetics
CYTK
|
$13.2M |
| 2 |
Rezolute
RZLT
|
$7.77M |
| 3 |
CG Oncology
CGON
|
$5.02M |
| 4 |
Delcath Systems
DCTH
|
$4M |
| 5 |
Fennec Pharmaceuticals
FENC
|
$2.18M |
Top Sells
| 1 |
Abeona Therapeutics
ABEO
|
$8.6M |
| 2 |
UroGen Pharma
URGN
|
$5.58M |
| 3 |
Nuvation Bio
NUVB
|
$4.31M |
| 4 |
IDEAYA Biosciences
IDYA
|
$3.97M |
| 5 |
Verastem
VSTM
|
$2.49M |
Sector Composition
| 1 | Healthcare | 100% |
